Browsing Tag
Pharmaceutical Manufacturing
36 posts
Vetter announces major global expansion with investments in US and Germany
Vetter, a leading global contract development and manufacturing organization (CDMO), has unveiled significant expansion plans, which include relocating…
Ingersoll Rand announces $2.3bn acquisition of ILC Dover from New Mountain Capital
Ingersoll Rand Inc. (NYSE:IR), renowned for its mission-critical flow creation and industrial solutions, has entered a definitive agreement…
Lupin Limited appoints Christoph Funke as Chief Technical Operations Officer to spearhead global pharmaceutical operations
Lupin Limited, a global leader in the pharmaceutical industry, announced today the strategic appointment of Christoph Funke to…
Switzerland-based CARBOGEN AMCIS achieves ANVISA GMP certification for Shanghai facility
In a significant achievement for Switzerland-based CARBOGEN AMCIS, a leading name in pharmaceutical process development and Active Pharmaceutical…
Zydus Lifesciences gains FDA aproval for Chlorpromazine Hydrochloride Injection
In a notable development for the pharmaceutical industry, Zydus Lifesciences Limited, along with its subsidiaries and affiliates, has…
Strides Pharma Science secures FDA approval for Gabapentin tablets
In a notable advancement for neuropathic pain treatment, Strides Pharma Science Limited (Strides) has announced that its step-down…
Bajaj Healthcare forges CDMO agreement with UK/EU clients for API supply
Bajaj Healthcare Ltd., a prominent figure in the pharmaceutical industry specializing in the manufacturing of Active Pharmaceutical Ingredients…
Lupin Limited announces satisfactory FDA inspection results for Mandideep facility
Global pharmaceutical major, Lupin Limited (Lupin), has announced receiving the Establishment Inspection Report (EIR) from the United States…
Can Lupin’s clean FDA inspection at its Vizag API plant boost confidence in its global supply reliability?
Lupin’s Vizag API plant clears US FDA inspection with no observations, strengthening its US supply reliability and regulatory track record.
US FDA issues Form 483 to Alkem Laboratories for St. Louis manufacturing plant after pre-approval inspection
US FDA issues Form 483 to Alkem Laboratories’ St. Louis plant after a pre-approval inspection. Learn what this means for its US market plans.